切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2024, Vol. 18 ›› Issue (02) : 106 -110. doi: 10.3877/cma.j.issn.1674-0793.2024.02.004

论著

磁共振成像与计算机断层扫描在胰腺导管腺癌血管侵犯术前评估中的价值比较
佘响云1, 周小琦2, 谢定祥2, 陈笑芳2, 张印宏2, 冯仕庭2, 蔡华崧2,()   
  1. 1. 518000 深圳市中医院放射科
    2. 510080 广州,中山大学附属第一医院放射科
  • 收稿日期:2024-01-15 出版日期:2024-04-01
  • 通信作者: 蔡华崧
  • 基金资助:
    中华国际医学交流基金会2020 SKY影像科研基金科研公益项目(Z-2014-07-2003-07)

Comparison of magnetic resonance imaging and computed tomography in the preoperative evaluation of peripancreatic vascular invasion in pancreatic ductal adenocarcinoma

Xiangyun She1, Xiaoqi Zhou2, Dingxiang Xie2, Xiaofang Chen2, Yinhong Zhang2, Shiting Feng2, Huasong Cai2,()   

  1. 1. Department of Radiology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518000, China
    2. Department of Radiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2024-01-15 Published:2024-04-01
  • Corresponding author: Huasong Cai
引用本文:

佘响云, 周小琦, 谢定祥, 陈笑芳, 张印宏, 冯仕庭, 蔡华崧. 磁共振成像与计算机断层扫描在胰腺导管腺癌血管侵犯术前评估中的价值比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(02): 106-110.

Xiangyun She, Xiaoqi Zhou, Dingxiang Xie, Xiaofang Chen, Yinhong Zhang, Shiting Feng, Huasong Cai. Comparison of magnetic resonance imaging and computed tomography in the preoperative evaluation of peripancreatic vascular invasion in pancreatic ductal adenocarcinoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(02): 106-110.

目的

对比磁共振成像(MRI)与计算机断层扫描(CT)在诊断胰腺导管腺癌(PDAC)的胰周血管侵犯中的应用价值。

方法

选择2019 年6 月至2022 年5 月中山大学附属第一医院82例经手术切除或开腹探查且病理诊断为PDAC 的患者,根据手术结果证实其中发生血管侵犯25 例,无血管侵犯57 例。患者均进行MRI 与CT 检查,分别评估两种检查方式对胰周动、静脉侵犯的诊断效能,并对比单用一种检查方式与联合两种检查的评估结果的诊断差异。

结果

MRI 和CT 评估静脉侵犯时的敏感度和特异度差异无统计学意义,而MRI 对发生静脉侵犯的区分能力优于CT(P<0.05);MRI 和CT 评估动脉侵犯时的敏感度和判断能力差异无统计学意义,而MRI 特异度优于CT(P<0.001);MRI 联合CT 后评估的敏感度提高,对血管侵犯的判断能力优于CT(P<0.05)。

结论

MRI 较CT 更适用于评估PDAC 胰周静脉侵犯,MRI 联合CT 可以提高对PDAC 血管侵犯的诊断敏感度。

Objective

To compare the value of magnetic resonance imaging (MRI) and computed tomography (CT) in the diagnosis of peripancreatic vascular invasion in pancreatic ductal adenocarcinoma(PDAC).

Methods

Eighty-two patients with PDAC diagnosed pathologically by surgical resection or laparotomy in the First Affiliated Hospital of Sun Yat-sen University from June 2019 to May 2022 were selected.Among them, 25 cases with vascular invasion and 57 cases without vascular invasion were confirmed according to the surgical results.All patients were examined by MRI and CT.The diagnostic efficacy of the two modalities for peripancreatic arterial and venous invasion was evaluated separately.The diagnostic differences between the results of one modality alone and the combination of the two modalities were compared.

Results

The differences in sensitivity and specificity between MRI and CT in assessing venous invasion were not statistically significant, while the aera under the curve (AUC) of MRI was better than CT (P<0.05); the differences in sensitivity and judgment between MRI and CT in assessing arterial invasion were not statistically significant, while the specificity of MRI was better than that of CT (P<0.001).When MRI was combined with CT, the sensitivity of assessment was increased and the judgment ability of vascular invasion was better than CT (P<0.05).

Conclusion

MRI is more suitable than CT for assessing peripancreatic venous invasion in PDAC, and combination of MRI with CT can improve the diagnostic sensitivity of vascular invasion in PDAC.

表1 胰腺导管腺癌和胰周血管关系的MRI和CT评估结果(n)
表2 MRI和CT评估门静脉-肠系膜上静脉侵犯的诊断效能(n)
表3 MRI 和CT 评估胰周动脉侵犯的诊断效能(n)
图1 三种检查方法诊断胰腺导管腺癌血管侵犯的效能对比 A 为诊断静脉侵犯;B 为诊断动脉侵犯
表4 对比MRI、CT 单独和联合评估胰周血管侵犯的诊断效能
图2 一例胰腺导管腺癌患者的MRI 和CT 影像 T2WI MRI 显示胰头区肿块,包绕肠系膜上静脉超180°,管腔狭窄且管壁不规则,提示血管侵犯(A);增强扫描MRI示胰头区病灶不均匀强化,肠系膜上静脉管腔狭窄且管壁不规则(B);DWI 示病灶的边界(C); CT 平扫及增强图像示肿瘤边界不清,包绕肠系膜上静脉超180°,管腔未见狭窄,未提示血管侵犯(D、E、F);白色箭头示肠系膜上静脉;三角箭头示肿瘤病灶
图3 另一例胰腺导管腺癌病例的MRI 和CT 影像 T2WI MRI 显示胰头区肿块,包绕肠系膜上静脉超180°,管壁不规则,提示血管侵犯(A);增强扫描MRI 示肠系膜上静脉管腔狭窄且管壁不规则(B); DWI 示病灶的边界,包绕肠系膜上静脉超180°(C); CT 平扫及增强图像,示病灶边界不清,包绕肠系膜上静脉超180°,管腔狭窄且管壁不规则,提示血管侵犯(D、E、F);白色箭头示肠系膜上静脉;三角箭头示肿瘤病灶
[1]
Park W, Chawla A, O'Reilly EM.Pancreatic cancer: A review[J].JAMA.2021, 326(9): 851-862.
[2]
Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3): 209-249.
[3]
张太平, 翁桂湖, 刘悦泽.不断推进中国腹腔镜胰腺癌手术规范化[J/OL].中华普外科手术学杂志(电子版), 2023, 17(2):120-123.
[4]
国家卫生健康委办公厅.胰腺癌诊疗指南(2022 年版)[J].临床肝胆病杂志, 2022, 38(5): 1006-1030.
[5]
National Comprehensive Cancer Network.NCCN guidelines:Pancreatic Adenocarcinoma[J/OL].NCCN, 2023.https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455.
[6]
Ren L, Jäger C, Schorn S, et al.Arterial resection for pancreatic cancer: feasibility and current standing in a high-volume center.Annals of surgery open: perspectives of surgical history, education,and clinical approaches[J].Ann Surg Open, 2023, 4(3): e302.
[7]
Brown Zachary J, Heh Victor, Labiner Hanna E, et al.Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis[J].Br J Surg, 2022, 110:34-42.
[8]
Harder FN, Jung E, McTavish S, et al.High-resolution, high b-value computed diffusion-weighted imaging improves detection of pancreatic ductal adenocarcinoma[J].Cancers (Basel), 2022,14(3): 470.
[9]
Choi TW, Lee JM, Kim JH, et al.Comparison of multidetector CT and gadobutrol-enhanced MR imaging for evaluation of small,solid pancreatic lesions[J].Korean J Radiol, 2016, 17(4): 509-521.
[10]
Noda Y, Kawai N, Kaga T, et al.Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrastenhanced MRI: comparison with pancreatic protocol CT[J].Abdom Radiol (NY), 2022, 47(8): 2835-2844.
[11]
Zhou X, Xu D, Wang M, et al.Preoperative assessment of peripheral vascular invasion of pancreatic ductal adenocarcinoma based on high-resolution MRI[J].BMC Cancer, 2023, 23(1): 1092.
[12]
许源澎, 李冬筱, 丁向明, 等.胰腺癌外科治疗指南要点解读[J].肝胆外科杂志, 2023, 31(4): 248-252.
[13]
陈坤斌, 黄为璋, 林忠良.MSCT 及MRI 在诊断及术前评估胰腺癌患者的价值[J].现代医用影像学, 2023, 32(2): 311-314.
[14]
李悦.CT 增强及3.0T 磁共振增强对胰腺癌及周围血管侵犯情况评价的初步研究[D].沈阳: 中国医科大学, 2019.
[15]
Seo W, Kim YC, Min SJ, et al.Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: correlation with pathologic grading[J].World J Gastroenterol, 2020, 26(28): 4151-4158.
[16]
Schneider M, Hackert T, Strobel O, et al.Technical advances in surgery for pancreatic cancer[J].Br J Surg, 2021, 108(7): 777-785.
[17]
江曼, 张京刚, 陈杰, 等.CT 评估胰腺癌血管侵犯分级的研究进展[J].国际医学放射学杂志, 2021, 44(6): 688-691, 697.
[18]
刘华, 郝凯, 翟冬枝.3.0T 磁共振多期增强扫描对胰腺癌术前诊断及手术可切除性评估中的价值[J].中国CT 和MRI 杂志,2019, 17(3): 90-93.
[19]
Ankush J, Ashley W, Mostafa A, et al.MRI vs.CT for pancreatic adenocarcinoma vascular invasion: comparative diagnostic test accuracy systematic review and meta-analysis[J].Eur Radiol,2023, 33: 6883-6891.
[20]
Elbanna KY, Jang HJ, Kim TK.Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: A comprehensive review[J].Insights Imaging, 2020, 11(1): 58.
[21]
廖娟, 鲜锟, 杨菊生, 等.MRI 联合MSCT 在胰腺癌术前诊治中的应用[J].中国CT 和MRI 杂志, 2020, 18(8): 111-113.
[1] 黄小辉, 王紫娟, 周围, 郭琼, 廖妮, 谭米多. 乳腺腺样囊性癌的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(01): 54-57.
[2] 陈思敏, 毛杰, 杜潇利, 张树泽. CT 与生物电阻抗法测定胃癌患者骨骼肌质量的比较研究[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 28-33.
[3] 张忠涛, 高加勒, 姚宏伟. 新辅助放化疗联合免疫治疗局部进展期直肠癌的现状与前景[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 119-122.
[4] 姚宏伟, 孙丽婷, 吴偲, 舒文龙, 高加勒, 杨正阳, 吴国聪, 张忠涛. 新辅助放化疗联合免疫治疗局部进展期直肠癌的探索与实践[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 123-127.
[5] 王乾宇, 杜峻峰, 李世拥. 新辅助放化疗联合免疫治疗局部进展期直肠癌的突破与挑战[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 128-131.
[6] 肖建, 肖天保, 陈江, 杨桃, 何峰, 保甜甜, 曹一波, 杨琴, 赵颖. 吲哚菁绿成像技术在保留左结肠动脉的直肠癌根治术中的应用价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 134-137.
[7] 韦洋, 赵远权, 王小波, 黄海, 陈洁. BCLC 0/A期肝细胞癌患者术后辅助治疗后早期复发风险分析及预测模型建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 157-161.
[8] 艾世超, 孙艺文, 宋鹏, 沈晓菲, 刘颂, 孙锋, 陆晓峰, 王萌, 管文贤. 静脉注射吲哚菁绿导航胃癌根治术的单臂开放前瞻性研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 166-169.
[9] 李峥, 马晋峰. 基于炎症反应评分系统构建预测根治性术后食管胃结合部腺癌患者预后的列线图模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 170-175.
[10] 何友新, 韩林荟, 杨贺庆. 新辅助化疗分别联合保乳术和改良根治术治疗Ⅱ、Ⅲ期乳腺癌的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 184-187.
[11] 董家旭, 宋美姿, 毕讯. 射频消融术联合TSH抑制治疗甲状腺微小乳头状癌的效果及生存预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 200-203.
[12] 孙建, 赵明慧, 赵恩春, 刘威辰. 经胸乳入路腔镜手术治疗甲状腺癌的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 204-207.
[13] 潘银珍, 张秀玉, 麦燕桃, 梁智强. 两种术式治疗肝内胆管细胞癌的临床疗效研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 208-211.
[14] 姚宏伟, 孙丽婷. 腹腔镜中低位直肠癌新辅助放化疗联合免疫治疗后根治性保肛术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 132-132.
[15] 罗添龙, 贺情情, 黄海. 泌尿功能障碍慢性病的长期综合管理和持久康复实践[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 21-26.
阅读次数
全文


摘要